# ROFLUMILAST
> **ANDA208257** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2018-07-13
## Drug
- **FDA Application Number:** ANDA208257
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROFLUMILAST
- **Generic name:** Roflumilast
- **Active ingredients:** ROFLUMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2018-07-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208257)
---
*MORVS · CC0 1.0*